STOCK TITAN

[Form 4] INCYTE CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Incyte Corp director Paul J. Clancy acquired 285 shares of Incyte common stock on 09/30/2025 at a price of $84.81 per share through restricted shares issued in lieu of quarterly director retainer fees under the company’s Amended and Restated 2010 Stock Incentive Plan; those restricted shares are reported as fully vested.

Following this transaction, the reporting person beneficially owns 23,235 shares in total, which includes an aggregate of 2,518 shares issuable upon previously reported restricted stock units that have not vested.

Il direttore di Incyte Corp, Paul J. Clancy, ha acquisito 285 azioni ordinarie di Incyte il 30/09/2025 al prezzo di $84.81 per azione, tramite azioni ristrette emesse al posto delle indennità trimestrali per i direttori ai sensi del Piano Incentivi Azionari del 2010, come emendato e riassunto; tali azioni ristrette sono riportate come pienamente maturate.

Dopo questa operazione, la persona che segnala detiene beneficiariamente in totale 23,235 azioni, tra cui un ammontare complessivo di 2,518 azioni assegnabili a unità azionarie ristrette precedentemente riportate che non hanno ancora maturato.

El director de Incyte Corp, Paul J. Clancy, adquirió 285 acciones comunes de Incyte el 30/09/2025 a un precio de $84.81 por acción mediante acciones restringidas emitidas en lugar de las comisiones trimestrales de director según el Plan de Incentivos de Acciones de 2010, enmendado y reformulado; esas acciones restringidas se informan como plenamente adquiridas.

Tras esta operación, la persona reportante posee en total 23,235 acciones, que incluyen un agregado de 2,518 acciones susceptibles de ser emitidas en virtud de unidades de acciones restringidas que habían sido reportadas previamente y que no han vencido.

Incyte Corp의 이사인 Paul J. Clancy2025년 9월 30일에 주당 $84.81의 가격으로 285주의 일반주를 매입했으며, 이는 회사의 2010년 주식 인센티브 계획(수정 및 재작성)에 따라 분기 이사 보수 대신 지급되는 제한 주식으로 발행된 것에 해당하며, 그 제한 주식은 이미 완전하게 취득으로 보고됩니다.

이 거래 후 보고자는 총 23,235주의 주식을 지분으로 보유하게 되며, 이는 이미 보고된 제한주식유닛이 아직 취득되지 않은 2,518주를 포함합니다.

Le directeur d'Incyte Corp, Paul J. Clancy , a acquis 285 actions ordinaires d'Incyte le 30/09/2025 au prix de $84.81 par action, par le biais d'actions restreintes émises au lieu des frais trimestriels de rétention des administrateurs en vertu du Plan d'incitation à l'action de 2010, tel que modifié et révisé; ces actions restreintes sont rapportées comme entièrement acquises.

Suite à cette transaction, la personne déclarant détient de manière bénéficiaire un total de 23,235 actions, ce qui inclut un total de 2,518 actions susceptibles d'être émises au titre d'unités d'actions restreintes qui avaient été précédemment déclarées et qui ne sont pas encore acquises.

Der Direktor von Incyte Corp, Paul J. Clancy, erwarb am 30.09.2025 285 Incyte Stammaktien zu einem Preis von $84.81 pro Aktie durch eingeschränkte Aktien, die anstelle von vierteljährlichen Direktorenhonoraren gemäß dem geänderten und neu gefassten Aktienanreizplan von 2010 ausgegeben wurden; diese eingeschränkten Aktien werden als vollständig vestet gemeldet.

Nach dieser Transaktion besitzt die meldende Person insgesamt 23,235 Aktien, wozu ein aggregierter Bestandteil von 2,518 Aktien gehört, die aufgrund zuvor gemeldeter Restricted Stock Units ausgegeben werden können, die noch nicht vestet sind.

عضو مجلس إدارة Incyte Corp، Paul J. Clancy اشترى 285 سهماً من أسهم Incyte العادية في 30/09/2025 بسعر $84.81 للسهم من خلال أسهم مقيدة صدرت بدلاً من رسوم الاحتفاظ الربعيّة للمجلس وفق خطّة الحوافز للأسهم لعام 2010 المعدّلة والمعاد صياغتها؛ وتُذكر تلك الأسهم المقيدة باعتبارها كاملة التملّك.

بعد هذه المعاملة، أصبح يمتلك الشخص المُبلّغ عنه ملكية فاعلة إجماليّاً 23,235 سهماً، وتشمل مجموعة إجمالية من 2,518 سهماً قابلة للإصدار بموجب وحدات الأسهم المقيدة التي تمت الإبلاغ عنها سابقاً والتي لم تتحقق بعد.

Incyte Corp 的董事 Paul J. Clancy2025/09/30 以每股 $84.81 的价格通过以限制性股票形式发行的方式取得 285 股 Incyte 普通股,作为公司经修订并重新表述的 2010 年股票激励计划下的董事季度报酬替代方案;这些限制性股票被报告为已完全归属。

在本次交易之后,报告人实际拥有总共 23,235 股,其中还包括以前报告的限制性股票单位所可发行的 2,518 股尚未归属的部分。

Positive
  • 285 shares acquired by director via equity election, showing insider purchase
  • Reporting person beneficial ownership totals 23,235 shares, indicating meaningful insider stake
Negative
  • None.

Insights

Director accepted equity in lieu of cash and increased reported ownership modestly.

The director received 285 restricted shares at $84.81 each on 09/30/2025 as an election to take stock rather than cash compensation, indicating use of the issuer’s stock incentive plan for non-employee director fees.

The report shows total beneficial ownership of 23,235 shares, including 2,518 unvested shares tied to prior restricted stock units, which is relevant for disclosure of insider alignment with shareholders.

Il direttore di Incyte Corp, Paul J. Clancy, ha acquisito 285 azioni ordinarie di Incyte il 30/09/2025 al prezzo di $84.81 per azione, tramite azioni ristrette emesse al posto delle indennità trimestrali per i direttori ai sensi del Piano Incentivi Azionari del 2010, come emendato e riassunto; tali azioni ristrette sono riportate come pienamente maturate.

Dopo questa operazione, la persona che segnala detiene beneficiariamente in totale 23,235 azioni, tra cui un ammontare complessivo di 2,518 azioni assegnabili a unità azionarie ristrette precedentemente riportate che non hanno ancora maturato.

El director de Incyte Corp, Paul J. Clancy, adquirió 285 acciones comunes de Incyte el 30/09/2025 a un precio de $84.81 por acción mediante acciones restringidas emitidas en lugar de las comisiones trimestrales de director según el Plan de Incentivos de Acciones de 2010, enmendado y reformulado; esas acciones restringidas se informan como plenamente adquiridas.

Tras esta operación, la persona reportante posee en total 23,235 acciones, que incluyen un agregado de 2,518 acciones susceptibles de ser emitidas en virtud de unidades de acciones restringidas que habían sido reportadas previamente y que no han vencido.

Incyte Corp의 이사인 Paul J. Clancy2025년 9월 30일에 주당 $84.81의 가격으로 285주의 일반주를 매입했으며, 이는 회사의 2010년 주식 인센티브 계획(수정 및 재작성)에 따라 분기 이사 보수 대신 지급되는 제한 주식으로 발행된 것에 해당하며, 그 제한 주식은 이미 완전하게 취득으로 보고됩니다.

이 거래 후 보고자는 총 23,235주의 주식을 지분으로 보유하게 되며, 이는 이미 보고된 제한주식유닛이 아직 취득되지 않은 2,518주를 포함합니다.

Le directeur d'Incyte Corp, Paul J. Clancy , a acquis 285 actions ordinaires d'Incyte le 30/09/2025 au prix de $84.81 par action, par le biais d'actions restreintes émises au lieu des frais trimestriels de rétention des administrateurs en vertu du Plan d'incitation à l'action de 2010, tel que modifié et révisé; ces actions restreintes sont rapportées comme entièrement acquises.

Suite à cette transaction, la personne déclarant détient de manière bénéficiaire un total de 23,235 actions, ce qui inclut un total de 2,518 actions susceptibles d'être émises au titre d'unités d'actions restreintes qui avaient été précédemment déclarées et qui ne sont pas encore acquises.

Der Direktor von Incyte Corp, Paul J. Clancy, erwarb am 30.09.2025 285 Incyte Stammaktien zu einem Preis von $84.81 pro Aktie durch eingeschränkte Aktien, die anstelle von vierteljährlichen Direktorenhonoraren gemäß dem geänderten und neu gefassten Aktienanreizplan von 2010 ausgegeben wurden; diese eingeschränkten Aktien werden als vollständig vestet gemeldet.

Nach dieser Transaktion besitzt die meldende Person insgesamt 23,235 Aktien, wozu ein aggregierter Bestandteil von 2,518 Aktien gehört, die aufgrund zuvor gemeldeter Restricted Stock Units ausgegeben werden können, die noch nicht vestet sind.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Clancy Paul J

(Last) (First) (Middle)
1801 AUGUSTINE CUT-OFF

(Street)
WILMINGTON DE 19803

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 09/30/2025 A 285 A $84.81 23,235(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1. Restricted shares are fully vested.
2. This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Remarks:
/s/ Elizabeth Feeney, Attorney-In-Fact 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did INCY director Paul J. Clancy report?

He reported acquisition of 285 restricted shares on 09/30/2025 at $84.81 per share.

Are the restricted shares acquired by the director vested?

Yes, the Form 4 states the restricted shares issued in lieu of fees are fully vested.

How many total Incyte shares does the reporting person beneficially own after the transaction?

The reporting person beneficially owns 23,235 shares following the reported transaction.

Does the beneficial ownership include unvested restricted stock units?

Yes, it includes an aggregate of 2,518 shares issuable pursuant to previously reported restricted stock units that have not vested.

Under what plan were the restricted shares issued?

The restricted shares were issued under the Issuer's Amended and Restated 2010 Stock Incentive Plan.
Incyte Corp

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Latest SEC Filings

INCY Stock Data

17.03B
190.92M
2.03%
103.47%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
WILMINGTON